These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


289 related items for PubMed ID: 8300885

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Nonpeptide angiotensin II-receptor antagonists].
    Inada Y, Wada T, Shibouta Y, Nishikawa K.
    Nihon Yakurigaku Zasshi; 1994 Sep; 104(3):217-28. PubMed ID: 7959414
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effects of U-97018 on pressor responses to intracerebroventricularly administered angiotensin II in conscious normotensive rats.
    Morita O, Kushida H, Kunihara M.
    J Cardiovasc Pharmacol; 1995 Jun; 25(6):880-7. PubMed ID: 7564332
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Direct selective blockade of the vascular angiotensin II receptors in therapy for hypertension and severe congestive heart failure.
    Awan NA, Mason DT.
    Am Heart J; 1996 Jan; 131(1):177-85. PubMed ID: 8554006
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Different types of antagonism by losartan and irbesartan on the effects of angiotensin II and its degradation products in rabbit arteries.
    Li Q, Pfaffendorf M, van Zwieten PA.
    Fundam Clin Pharmacol; 2001 Apr; 15(2):143-50. PubMed ID: 11468024
    [Abstract] [Full Text] [Related]

  • 13. Angiotensin receptors: physiology and pharmacology.
    Guthrie GP.
    Clin Cardiol; 1995 Jun; 18(6 Suppl 3):III 29-34. PubMed ID: 7634561
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Angiotensin II receptor antagonism: losartan - sites and mechanisms of action.
    Triggle DJ.
    Clin Ther; 1995 Jun; 17(6):1005-30. PubMed ID: 8750395
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Discovery of losartan, the first angiotensin II receptor antagonist.
    Timmermans PB, Duncia JV, Carini DJ, Chiu AT, Wong PC, Wexler RR, Smith RD.
    J Hum Hypertens; 1995 Nov; 9 Suppl 5():S3-18. PubMed ID: 8583479
    [Abstract] [Full Text] [Related]

  • 19. Different types of receptor interaction of peptide and nonpeptide angiotensin II antagonists revealed by receptor binding and functional studies.
    Wienen W, Mauz AB, Van Meel JC, Entzeroth M.
    Mol Pharmacol; 1992 Jun; 41(6):1081-8. PubMed ID: 1614410
    [Abstract] [Full Text] [Related]

  • 20. Effect of angiotensin II blockade on cardiac hypertrophy and remodelling: a review.
    Dahlöf B.
    J Hum Hypertens; 1995 Nov; 9 Suppl 5():S37-44. PubMed ID: 8583480
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 15.